Antioxidant therapy in acute central nervous system injury: Current state

Pharmacological Reviews

Volumn 54, Issue 2, 2002, Pages 271-284

  Gilgun Sherki, Yossi ^a   Rosenbaum, Ziv ^a   Melamed, Eldad ^a   Offen, Daniel ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

2,6 DI TERT BUTYL 4 [(ETHYLAMINO)METHYL]PHENOL; 21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; ACETYLCYSTEINE; ALPHA TOCOPHEROL; ALPHA TOCOPHEROL DERIVATIVE; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; DEFEROXAMINE; DEFEROXAMINE MESYLATE; DNA; EBSELEN; FREE RADICAL; GLUTAMIC ACID; GLUTATHIONE ISOPROPYL ESTER; MDL 74722; MELATONIN; N (7 HYDROXY 2,2,4,6 TETRAMETHYL 1 INDANYL) 4 (3 METHOXYPHENYL) 1 PIPERAZINEACETAMIDE; NICARAVEN; NORPHENAZONE; PHENYL ALPHA TERT BUTYL NITRONE; POLYAMINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; SPERMIDINE; SPERMINE; THIOCTIC ACID; TIRILAZAD; UBIQUINONE; UNCLASSIFIED DRUG; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; BLOOD BRAIN BARRIER; BRAIN INJURY; BRAIN ISCHEMIA; CELL RESPIRATION; CELL SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; MOUSE; MULTICENTER STUDY; NERVOUS SYSTEM INJURY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RAT; REVIEW; STROKE; TISSUE INJURY;

ACUTE DISEASE; ANIMALS; ANTIOXIDANTS; BLOOD-BRAIN BARRIER; BRAIN; CEREBROVASCULAR ACCIDENT; HUMANS; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIALS; REACTIVE OXYGEN SPECIES; TREATMENT OUTCOME;

EID: 0036262303     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: 10.1124/pr.54.2.271     Document Type: Review

References (195)

1. Strong attenuation of ischemic and postischemic brain edema in rats by novel free radical scavenger
2. Does consumption of fruit and vegetables protect against stroke?
3. Uric acid provides an antioxidant defense in humans against oxidant and radical caused aging and cancer: A hypothesis
4. Effects of treatment with U-74006F on neurological recovery following experimental spinal cord injury
5. Effects of delayed administration of U-74006F (tirilazad mesylate) on recovery of locomotor function following experimental spinal cord injury
6. Effects of a hydroxyl radical scavenger on delayed ischemic neurological deficits following aneurysmal subarachnoid hemorrhage
7. Mouse model of focal cerebral ischemia for screening neuroprotective drug effects
8. Exogenous creatine delays anoxic depolarization and protects from hypoxic damage: Dose effect relationship
9. Coenzyme Q content in synaptic and non-synaptic mitochondria from different brain regions in the aging rats
10. The effects of two 21-aminosteroids on overt infarct size 48 hours after middle cerebral artery occlusion in the rat
11. Cerebroprotective effect of stable nitroxide radicals in closed head injury in the rat
12. Biological functions of dietary carotenoids
13. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis
14. Lipid peroxidation: A review of causes, consequences, measurement and dietary influences
15. Uric acid: Friend or foe
16. Antioxidant properties of melatonin-an emerging mystery
17. An analysis of the role of coenzyme Q in free radical generation and as antioxidant
18. Tissue coenzyme Q (ubiquinone) and protein concentrations over the life span of the laboratory rat
19. Nutrition intervention trials in Linx-ian China: Supplementation with specific vitamin/mineral combination, cancer incidence, and disease-specific mortality in the general population
20. The relation of oxidative stress and hyperexcitation to neurological disease
21. Glial survival is enhanced during melatonin-induced neuroprotection against cerebral ischemia
22. Effects of excitotoxins on free radical indices in mouse brain
23. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury: Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial
24. Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radicals and lipid peroxidation
25. Increased lipid peroxidation in vulnerable brain regions after transient forebrain ischemia
26. Primary prevention of stroke
27. Massive persistent release of excitatory amino acids following human occlusive stroke
28. Synthesis of novel 2,4 diaminopyyrrolo-[2,3-d] pyrimidines with antioxidant neuroprotective and antiasthma activity
29. The free radical scavenger alpha-lipoic acid protects against cerebral ischemia-reperfusion injury in gerbils
30. Protection against oxidative damage to CNS by alpha-phenyl-tert-butyl nitrone (PBN) and other spin trapping agents: A novel series of nonlipid free radical scavengers
31. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spacial memory by chronic administration of the spin trapping compound N-tert-butyl-alpha- phenylnitrone
32. Superoxide and nitric oxide cooperation in hypoxia/reoxygenation-induced neuron injury
33. Partners in defense. Vitamin E and vitamin C
34. Reactive oxygen radicals in signaling and damage in the ischemic brain
35. Plasma levels of antioxidant vitamins, selenium, total sulfhydryl groups and oxidative products in ischemic-stroke patients as compared to matched controls in Taiwan
36. CNS pharmacology and current research
37. The antioxidant LY231617 reduces global ischemic neuronal injury in rats
38. Oxidative stress, glutamate and neurodegenerative disorders
39. Duration of glutamate release after acute ischemic stroke
40. Uric acid-iron complexes
41. Dietary vitamin C, beta-carotene and 30-year risk of stroke: Results from the western electric study
42. The neuroprotective efficacy of ebselen (aglutathione peroxidase mimic) on brain damage induced by transient focal cerebral ischemia in the rat
43. Primary stroke prevention
44. Physiological antioxidants and antioxidative enzymes in vitamin E-deficient rats
45. Accumulation of amino acids and hydroxyl free radicals in brain and retina of gerbil after transient ischemia
46. Malondialdehyde, glutathione peroxidase and superoxide dismutase in peripheral blood erythrocyres of patients with acute cerebral ischemia
47. Pathobiology of ischemic stroke: An integrated view
48. Enhanced sensitivity of ubiquinone-deficient mutants of saccharomyces cerevisiae to products of autooxidized polyunsaturated fatty acid
49. The role of excitotoxicity in neurodegenerative disease: Implications for therapy
50. Vitamin E enhances Ca (2+)-mediated vulnerability of immature cerebellar granule cells to ischemia
51. Oxidative stress and antioxidant theory in Parkinson's disease
52. Biochemical, physiological and medical aspects of ubiquinon function
53. Free radicals in brain metabolism and pathology
54. Free radicals as mediators of neuronal injury
55. The role of excitatory amino acids and NMDA receptors in traumatic head injury
56. The role of free radicals in NMDA-dependent neurotoxicity
57. Failure of deferoxamine, an iron chelator, to improve neurologic outcome following complete cerebral ischemia in dogs
58. Effect of gender and menopausal status on the pharmacokinetics of tirilazad mesylate in healthy subjects
59. N-tert-butyl-alpha-phenylnitrone improves recovery of brain energy state in rats following transient focal ischemia
60. Lipid peroxidation and changes in the ubiquinone content and the respiratory chain enzymes of submitochodrial particles
61. Ascorbate is an outstanding antioxidant in human blood plasma
62. Oxidative stress in the human brain after subarachnoid hemorrhage
63. The pathobiology of traumatic brain injury
64. Antivasospastic and brain-protective effects of a hydroxyl radical scavenger (AVS) after experimental subarachnoid hemorrhage
65. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel prospective study
66. Polyamines can protect against ischemia-induced nerve cell death in gerbil forebrain
67. Polyamines in neurotrauma ubiquitous molecule in search of a function
68. The concept of the therapeutic window: A synthesis of critical issues
69. 10 administration prevents the development of ischemic brain lesions in rabbit model of symptomatic vasospasm
70. Ischemia-induced shift to inhibitory and excitatory amino acids from intrato extra-cellular compartments
71. A randomized, double blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in North America
72. Effects of the 21-aminosteroid U-74006f on experimental head injury in mice
73. Effects of the 21-aminosteroid U-74006f on posttraumatic spinal cord ischemia in cats
74. Free radicals and CNS injury
75. Inhibition of lipid peroxidation in central nervous system trauma and ischemia
76. Pyrrolopyrimidnes novel brain penetrating antioxidants with neuroprotective activity in brain injury and ischemia models
77. Central nervous system trauma and stroke, physiological and pharmacological evidence for the involvement of oxygen radicals and lipid peroxidation
78. Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system: Trauma, ischemia and subarachnoid hemorrhage
79. 21-Aminosteroid U-74006F protects against cerebral ischemia in gerbils
80. Free radicals, antioxidants, and human disease: Curiosity, cause or consequence?
81. Antioxidants: The basics-what they are and how to evaluate them
82. Potentiation of quinolinate-induced hippocampal lesions by inhibition of NO synthesis
83. Functional recovery of cortical neurons as related to degree and duration of ischemia
84. Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease
85. Nitrone-based free radical traps as neuroprotective agents in cerebral ischemia and other pathologies
86. Blocking weight induced injury in rats: Therapeutic effect of 21-aminosteroid U-74006F
87. Creatine increases survival and suppress seizures in the hypoxic immature rat
88. Lazaroid compounds prevent early but not the late stages of oxidant induced cell injury: Potential explanation for the lack of efficacy of lazaroid in clinical trials
89. Deferoxamine reduces early metabolic failure associated with severe cerebral ischemic acidosis in dogs
90. Glial cells protect neurons against oxidative stress via transcriptional up-regulation of glutathione synthesis
91. Oxidative stress and the pathogenesis of Parkinson's disease
92. Polyamines and cerebral ischemia
93. Effects of ebselen (PZ51) on ischemic brain edema after focal ischemia in cats
94. Thresholds of focal cerebral ischemia in awake monkeys
95. Fruit and vegetable intake in relation to risk of ischemic stroke
96. Age related changes in the lipid composition of rat and human tissues
97. Temporal thresholds for neocortical infarction in rats subjected to reversible focal cerebral ischemia
98. Randomized, double blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in Europe, Australia, and New Zealand
99. Antioxidant OPC-14117, attenuates edema formation and behavioral deficits following cortical contusion in rats
100. Dietary flavonoids, antioxidant vitamins, and incidence of stroke: The Zutphen study
101. Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia
102. N-acetylcysteine enhances hippocampal neuronal survival after transient forebrain ischemia in rats
103. Pharmacologic properties of phenyl N-tert-butylnitrone
104. Delayed treatment with alpha-phenyl-tert-butyl nitrone (PBN) attenuates secondary mitochondrial dysfunction after focal cerebral ischemia in the rat
105. Functions of glutathione
106. Free radical pathway in CNS injury
107. Protective effect of melatonin on injured cerebral neurons is associated with bcl-2 protein over-expression
108. Oxidative stress in brain ischemia
109. Why have recent trials of neuroprotective agents in head injury failed to show convincing efficacy. A pragmatic analysis and theoretical considerations
110. U74389G prevents vasospasm after subarachnoid hemorrhage in dogs
111. Increased brain damage after stroke or excitotoxic seizures in melatonin-deficient rats
112. A multicentral on the efficacy of using tirilazad mesylate in cases of head injury
113. NFκB in neuronal plasticity and neurodegenerative disorders
114. The novel 21-aminosteroid U-74006F attenuates cerebral edema and improved survival after brain injury in the rat
115. Glutathione
116. Penumbral tissues salvaged by reperfusion following middle cerebral artery occlusion in rats
117. Depletion of brain glutathione by buthionine sulfoximine enhances cerebral ischemic injury in rats
118. Lung protection by a thiol containing antioxidant N-acetylcysteine
119. Creatine supplementation as an ergogenic acid for sports performance in highly trained athletes: A critical review
120. A novel biologically active seleno-organic compound. I. Glutathione peroxidase like activity in vitro and antioxidant capacity of PZ51 (Ebselen)
121. Glutamate release and neuronal damage in ischemia
122. Relations between tocopherol depletion and coenzyme Q during lipid peroxidation in rat liver mitochondria
123. S-Allylcysteine inhibits free radical production, lipid peroxidation, and neuronal damage in rat brain ischemia
124. Ebselen in acute middle cerebral artery occlusion: A placebo-controlled double-blind clinical trial
125. 10, and naloxone on experimental stroke
126. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain
127. Neuroprotective effect of the antioxidant LY231617 and NO synthase inhibitors in global cerebral ischemia
128. New horizons in antioxidant research: Action of the thioctic acid/dihydrolipoic acid couple in biological systems, in Thioctsaure
129. Alpha-lipoic acid: A metabolic antioxidant which regulates NF-kappa B signal transduction and protects against oxidative injury
130. Neuroprotection by the metabolic antioxidant and α-lipoic acid
131. Cellular functions of ascorbic acid
132. Effect of the spin trap-alpha-phenyl-N-tert-butyl nitrone (PBN) in transient forebrain ischemia
133. Deferoxamine post-treatment reduces ischemic brain injury in neonatal rats
134. Dose response analysis of the tirilazad mesylate (U-74006F) upon neurological outcome and ischemic brain damage in permanent focal cerebral ischemia
135. Excitatory amino acids release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage
136. Dihydro-lipoate reduces neuronal injury after cerebral ischemia
137. Pathophysiology of stroke
138. The therapeutic window in ischemic brain injury
139. Use of biophysical-kinetic model to understand the roles of protein binding and membrane partitioning on passive diffusion of highly lipophilic molecules across cellular barriers
140. Fine structural localization of a blood brain barrier to exogenous peroxidase
141. Ascorbate regulation and its neuroprotective role in the brain
142. Differential compartmentalization of brain ascorbate and glutathione between neurons and glia
143. Regulation of gamma-glutamyl-cystein, synthetase by non allosteric feedback inhibition by glutathione
144. Biology of free radical scavengers: An evaluation of ascorbate
145. Cerebrospinal fluid: Blood brain barrier oedema and hydrocephalus
146. Neuroprotective efficacy of an antioxidant ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage
147. Effect of U-74006F on neurological function and brain edema after fluid percussion injury in rats
148. Hemoglobin potentiates nervous system damage
149. The neuroprotective effect of deferoxamine in the hypoxic-ischemic immature mouse brain
150. Superior neuroprotective efficacy of a novel antioxidant (U-101033E) with improved blood-brain barrier permeability in focal cerebral ischemia
151. NFκB is activated and promotes cell death in focal cerebral ischemia
152. Ascorbic acid in the brain
153. Facilitation of postischemic reperfusion with alpha PBN: Assessment using NMR and Doppler flow techniques
154. Redox signaling and the emerging therapeutic potential of thiol antioxidants
155. Alpha-phenyl-tert-butyl nitrone (PBN) attenuates hydroxyl radical production during ischemia-reperfusion injury in rat brain: An EPR study
156. Serum urate as an antioxidant for ascorbic acid
157. Multiple molecular penumbras after focal cerebral ischemia
158. Glutathione and protein thiol homeostasis in brain during reperfusion after cerebral ischemia
159. Oxidative stress in closed head injury: Brain antioxidant capacity as an indicator of functional outcome
160. Pathophysiology and treatment of focal cerebral ischemia
161. Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanism of damage and treatment
162. Basic mechanisms of traumatic brain damage
163. U-74006F, an inhibitor of lipid peroxidation, protects against lesion development following stroke in the cat: Histological and metabolic analysis
164. Oxidative stress in neurodegenerative diseases
165. Direct measurement of hydroxyl radical levels, lipid peroxidation and blood-brain barrier disruption following unilateral head injury in the rat
166. Dietary supplement creatine protects against traumatic brain injury
167. Recombinant human superoxide dismutase can attenuate ischemic neuronal damage in gerbils
168. Neuroprotective efficacy of ebselen an antioxidant with anti-inflammatory actions, in rodent model of permanent middle cerebral artery occlusion
169. Cerebral uric acid increases following experimental traumatic brain injury in rat
170. Vitamin E in humans. Demand and delivery
171. Inhibition of iron-dependent and ischemia-induced brain damage by the α-tocopherol analogue MDL 74,722
172. Vitamin E: Neurochemistry and implication for Parkinson's disease
173. A study of the effectiveness of the iron-chelating agent deferoxamine as vasospasm prophylaxis in a rabbit model of subarachnoid hemorrhage
174. Does consumption of fruit and vegetables protect against stroke?
175. Ebselen (DR3305) ameliorates delayed cvasospasm in a canine two hemorrhage model
176. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma
177. A novel biologically active seleno-organic compound. II. Activity of PZ51 in relation to glutathione peroxidase like activity in vitro and antioxidant capacity of
178. Brain injury by ischemic anoxia: Hypothesis extension-a tale of two ions?
179. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species
180. Neuroprotective effects of alpha-lipoic acid and its enantiomers demonstrated in rodent models of focal cerebral ischemia
181. Tirilazad reduces cortical infarction after transient, but not permanent focal cerebral ischemia in rats
182. Ebselen in acute ischemic stroke: A placebo-controlled double-blind clinical trial
183. Protective actions of YM737, a new glutathione analog, against cerebral ischemia in rats
184. Improvement in cerebral blood flow and metabolism following subarachnoid hemorrhage in response to prophylactic administration of the hydroxyl radical scavenger, AVS, (±)-N,N′-propylenedinicotinamide
185. Intake of antioxidant vitamin and risk of death from stroke in postmenopausal women
186. Effects of pegorgotein on neurologic outcome of patients with severe head injury: A multicenter, randomized controlled trial
187. Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo
188. Alternations in the glutathione content of mitochondria following short term forebrain ischemia in rats
189. Mechanism of brain protection by nitroxide radicals in experimental model of closed head injury
190. Delayed treatment with the spin trap alpha-phenyl-tert-butyl nitrone (PBN) reduces infarct size following transient middle cerebral artery occlusion in rats
191. Factors determining the therapeutic window for stroke
192. Effect of the 21-aminosteroid U-74006F on cerebral vasospasm following subarachnoid hemorrhage